|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4200 AUD | +1.20% |
|
+13.51% | -2.33% |
| 04/03 | Daily Special: Island Pharmaceuticals, GenusPlus Group, Horizon Gold | FI |
| 04/03 | Island Pharmaceuticals Enters Agreement to Advance Galidesivir Approval, Shares Up 19% | MT |
| Capitalization | 124M 86.87M 74.9M 67.61M 64.87M 118M 7.98B 799M 320M 3.83B 326M 319M 13.69B | P/E ratio 2026 * |
-23.7x | P/E ratio 2027 * | -8.94x |
|---|---|---|---|---|---|
| Enterprise value | 124M 87.29M 75.26M 67.94M 65.19M 119M 8.02B 803M 322M 3.85B 328M 321M 13.76B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
31.21% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.20% | ||
| 1 week | +13.51% | ||
| Current month | +13.51% | ||
| 3 months | -20.75% | ||
| 6 months | +55.56% | ||
| Current year | -2.33% |
| 1 week | 0.4 |  | 0.44 |
| 1 month | 0.35 | | 0.45 |
| Current year | 0.35 | | 0.5 |
| 1 year | 0.12 | | 0.63 |
| 3 years | 0.05 | | 0.63 |
| 5 years | 0.05 | | 0.67 |
| 10 years | 0.05 | | 0.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Foster
CEO | Chief Executive Officer | - | 18/01/2021 |
Cameron Jones
DFI | Director of Finance/CFO | - | - |
Jane Lowe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 19/09/2024 | |
David Foster
BRD | Director/Board Member | - | 18/01/2021 |
Jason Carroll
CHM | Chairman | - | 02/07/2025 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.20% | +13.51% | +162.50% | +366.67% | 86.87M | |
| -0.61% | -5.35% | +12.03% | +92.93% | 44.16B | |
| +0.92% | -4.81% | +49.26% | +14.90% | 40.5B | |
| -2.40% | -6.16% | +87.11% | +608.08% | 30.21B | |
| -0.44% | -7.92% | -6.69% | -21.33% | 25.47B | |
| +2.54% | -9.65% | +53.01% | -34.70% | 19.22B | |
| -2.62% | -6.49% | +4.16% | -31.60% | 16.5B | |
| +5.20% | +0.37% | +47.19% | +154.57% | 12.64B | |
| +1.14% | -8.92% | -15.02% | +994.93% | 11.72B | |
| +4.43% | -0.31% | +55.98% | - | 11.51B | |
| Average | +0.94% | -3.22% | +44.95% | +238.27% | 21.2B | |
| Weighted average by Cap. | +0.29% | -5.16% | +33.74% | +174.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -4.6M -3.23M -2.78M -2.51M -2.41M -4.4M -297M -29.7M -11.9M -142M -12.11M -11.86M -509M | -13.2M -9.26M -7.99M -7.21M -6.92M -12.61M -851M -85.22M -34.14M -408M -34.76M -34.02M -1.46B |
| Net Debt | 600K 421K 363K 328K 314K 573K 38.69M 3.87M 1.55M 18.55M 1.58M 1.55M 66.36M | -18.2M -12.77M -11.01M -9.94M -9.54M -17.39M -1.17B -117M -47.07M -563M -47.93M -46.91M -2.01B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 0.4200 $ | +1.20% | 2,113,243 |
| 05/03/26 | 0.4150 $ | -2.35% | 361,493 |
| 04/03/26 | 0.4250 $ | +14.86% | 1,289,017 |
| 27/02/26 | 0.3700 $ | 0.00% | 36,244 |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ILA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition